Jaan Biotherapeutics Overview
- Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$55K
- Investors
-
3
Jaan Biotherapeutics General Information
Description
Developer of novel therapies designed to treat cardiovascular diseases. The company's therapies activate the cardiac regeneration process in diseased hearts using proprietary technology and activate an endogenous cardiac muscle regeneration process that has been shut down in the adult human heart during evolution, enabling healthcare providers to cure their patients and improve their lives.
Contact Information
Website
www.jaanbio.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 6331 Nancy Ridge Drive
- Suite 204
- San Diego, CA 92121
- United States
+1 (858) 000-0000
Jaan Biotherapeutics Timeline
Jaan Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 01-May-2021 | $55K | Completed | Startup | ||
| 3. Grant | 26-Oct-2020 | 00000 | Completed | Startup | ||
| 2. Angel (individual) | 10-Mar-2016 | Cancelled | Startup | |||
| 1. Accelerator/Incubator | 10-Mar-2016 | Completed | Startup |
Jaan Biotherapeutics Patents
Jaan Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4048398-A1 | Compositions and methods for mitigation of ischemic reperfusion injury | Pending | 21-Oct-2019 | ||
| US-20220307028-A1 | Compositions and methods for mitigation of ischemic reperfusion injury | Pending | 21-Oct-2019 | 0000000000 | |
| EP-3484526-A1 | Compositions and methods for treatment of cardiac diseases | Pending | 18-Jul-2016 | 0000000000 | |
| JP-2019521176-A | Compositions and methods for the treatment of heart disease | Pending | 18-Jul-2016 | 0000000000 | |
| JP-2020186249-A | Composition and method for treatment of cardiac disease | Pending | 18-Jul-2016 | C12N15/113 |
Jaan Biotherapeutics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Bhawanjit Brar Ph.D | Co-Founder & Chief Executive Officer | ||
| Joseph Hansen JD | Co-Founder & Chief Financial Officer |
Jaan Biotherapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
| CONNECT (Accelerator) | Accelerator/Incubator | 000 0000 | 000000 0 |